SCHEMBL15577017

SCHEMBL15577017

CC1CCCc2ccc(C#N)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.45
DRD3 P35462 4/20 0.45
LRRK2 Q5S007 4/20 0.44
KDM1A O60341 2/20 0.43
PNMT P11086 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NOS3 P29474 1/20 0.40
NOS1 P29475 1/20 0.40
NOS2 P35228 1/20 0.40
CYP11B2 P19099 1/20 0.39
CHRNA1 P02708 1/20 0.39
CHRNG P07510 1/20 0.39
CHRNB1 P11230 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA4 P43681 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24593614 1.00 DRD2 (0.45) DRD2DRD3LRRK2KDM1APNMT
SCHEMBL16906757 0.89 DRD2 (0.50) DRD2DRD3LRRK2KDM1APNMT
SCHEMBL24593570 0.89 DRD2 (0.50) DRD2DRD3LRRK2KDM1APNMT
SCHEMBL14072565 0.88 LRRK2 (0.46) DRD2DRD3LRRK2KDM1APNMT
SCHEMBL2818458 0.81 PGR (0.48) DRD2DRD3LRRK2KDM1APNMT
SCHEMBL6141623 0.81 CYP11B1 (0.49) DRD2DRD3LRRK2KDM1APNMT
SCHEMBL10192249 0.81 LRRK2 (0.44) DRD2DRD3LRRK2KDM1APNMT
SCHEMBL12058460 0.77 LRRK2 (0.43) DRD2DRD3LRRK2KDM1APNMT
SCHEMBL14450170 0.77 LRRK2 (0.43) DRD2DRD3LRRK2KDM1APNMT
SCHEMBL15491209 0.77 LRRK2 (0.43) DRD2DRD3LRRK2KDM1APNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020127685-A1 AMINO-ACID ANILIDES AS SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2020-06-25 WO disclosed
US-8674095-B2 Compounds for treating neuropsychiatric conditions AFRAXIS HOLDINGS, INC. (US) 2014-03-18 US disclosed
CN-1849121-A Piperazine derivatives as bradyknin antagonist AMGEN INC (US) 2006-10-18 CN disclosed